Search

Anita McSwain, MD,MPH,FACS
Anita McSwain, MD is board-certified in General Surgery and an assistant professor with The George Washington University School of Medicine & Health Sciences. She specializes in breast surgery at the Breast Care Center. Dr. McSwain is a graduate of The University of Richmond and the Johns…
Clinical Trial Change Request
Please use this form request to add, edit, or remove a clinical trial from this website. Requests are typically resolved within 5 business days.
Sunil Adige, MD
Dr. Sunil Adige is a Board Certified Medical Oncologist who specializes in treating patients with breast cancer. He completed his medical degree at Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia, PA. He then completed his internal medicine residency at the University…
Matthew Pyle, MD
Sonal Batra, MD, MST
Sonal Batra, MD, MST is Assistant Program Director for the Emergency Medicine Residency and oversees the residency curriculum.
Jennifer Wolf-Stuth, MD
Colleen Roche
Claudia Ranniger, MD, PhD
Dr.
A Phase II/III Randomized Study of Maintenance Nivolumab Versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPCA
Primary objective: to assess the efficacy of concurrent definitive therapy followed by nivolumab compared with concurrent definitive therapy followed by observation in terms of progression-free survival (PFS). (Phase II) II.
Randomized Phase II/III Trial of Radiation With High-Dose Cisplatin (100 mg/m2) Every Three Weeks Versus Radiation With Low-Dose Weekly Cisplatin (40 mg/m2) for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Randomized Phase II/III Trial of Radiation With High-Dose Cisplatin (100 mg/m2) Every Three Weeks Versus Radiation With Low-Dose Weekly Cisplatin (40 mg/m2) for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)